Emergency Medicine

Emergency Medicine

By ReachMDMedicine
Download on the App Store

Emergency Medicine episodes

  • Optimizing Your Pharmacologic Approach to Reversing Anticoagulation for ICH
    Host: David Seiffge, MD
    Host: Natalie Kreitzer, MD, MS
    Host: W. Brian Gibler, MD, FACEP, FACC, FAHA

    Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

    10 min
  • Neurosurgical Management of ICH: Making Sense of ENRICH, SWITCH, STICH and MISTIE
    Host: Hiren C. Patel, PhD, FRCS
    Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
    Host: Adrian R. Parry-Jones, FRCP, PhD
    Host: Thorsten Steiner, MD, PhD, MME

    Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

    14 min
  • ESO Guidelines for the Management of ICH in the Anticoagulated Patient
    Host: Thorsten Steiner, MD, PhD, MME
    Host: W. Brian Gibler, MD, FACEP, FACC, FAHA
    Host: David Seiffge, MD
    Host: Adrian R. Parry-Jones, FRCP, PhD
    Host: Natalie Kreitzer, MD, MS

    Dive deep into the critical care of anticoagulated patients with intracranial hemorrhage (ICH). Our panel of esteemed experts deliver essential insights into the latest treatment approaches, exploring recent data focused on reversing anticoagulation and the neurosurgical management of ICH. This program provides a comprehensive understanding of key strategies proven to be effective in these complex cases, highlighting the most up-to-date guideline-directed, evidence-based practices.

    13 min
  • ACC 2024: VOYAGER PAD Part 1
    Host: Marc P. Bonaca, MD, MPH

    This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

    6 min
  • ACC 2024: The PIONEER AF-PCI Trial
    Host: Manesh R. Patel, MD

    This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

    5 min
  • ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
    Host: Manesh R. Patel, MD

    This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

    6 min
  • ACC 2024: VOYAGER PAD Part 2
    Host: Marc P. Bonaca, MD, MPH

    This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

    6 min
  • ACC 2024: SHASTA-2 Final Study Results
    Host: Daniel Gaudet, MD, PhD

    This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

    6 min